GRAIL, Inc. Common Stock — 분기별 재무제표 (NASDAQ:GRAL)

전체 차트 열기

Financials

개요 성명 통계

4분기 연간

Market Capitalization 2.1359 B
Employee 910
Founded 2015
CEO N/A
Website www.grail.com
Headquarter Delaware, United States
FIGI BBG01N6CGW43
Industry 분석 & 리서치

총매출

순이익

주당 순이익(기본 EPS)

총부채

잉여 현금 흐름

현금 및 현금성 자산

2.14 B 시가 총액

주가수익비율

-7.7

주가매출액비율

21.37

GRAIL Inc

GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021. In June 2021 GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023 EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024.